SBI Securities’s Windtree Therapeutics WINT Stock Holding History

SBI Securities’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24	Closed	-$12	–	4326
2025 Q2	$12	Hold	24	–	–	﹤0.01%	3989
2025 Q1	$30	Buy	24 +23	+2,300%	+$142	﹤0.01%	3771
2024 Q4	$22	Buy	+1	New	+$32	﹤0.01%	3818

SBI Securities's WINT Position: Q3 2025 in Review

SBI Securities sold out of Windtree Therapeutics (WINT) in Q3 2025, closing a stake of 24 shares — an estimated $12 sold.

SBI Securities first reported a position in WINT in Q4 2024 and held it in 3 quarters. The position peaked at $30 in Q1 2025. 0 funds tracked by Wall St. Rank hold WINT as of Q3 2025.

SBI Securities reported no remaining Windtree Therapeutics position as of Q3 2025 after selling out during the quarter.
SBI Securities sold 24 Windtree Therapeutics shares in Q3 2025, an estimated $12.
SBI Securities first reported a position in Windtree Therapeutics in Q4 2024 and held it in 3 quarters.
SBI Securities's Windtree Therapeutics position peaked at $30 in Q1 2025.
0 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.